INFU icon

InfuSystem Holdings

6.21 USD
+0.11
1.80%
At close Jun 13, 4:00 PM EDT
After hours
5.90
-0.31
4.99%
1 day
1.80%
5 days
1.64%
1 month
8.00%
3 months
13.74%
6 months
-30.30%
Year to date
-23.14%
1 year
-6.90%
5 years
-47.46%
10 years
95.28%
 

About: InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

Employees: 514

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

11% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 27

9% more funds holding

Funds holding: 86 [Q4 2024] → 94 (+8) [Q1 2025]

0.15% more ownership

Funds ownership: 66.46% [Q4 2024] → 66.62% (+0.15%) [Q1 2025]

16% less call options, than puts

Call options by funds: $26K | Put options by funds: $31K

37% less capital invested

Capital invested by funds: $119M [Q4 2024] → $75.4M (-$44M) [Q1 2025]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for INFU.

Financial journalist opinion

Neutral
Seeking Alpha
1 month ago
InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q1 2025 Earnings Call May 8, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Richard Dilorio - CEO Barry Steele - EVP and CFO Carrie Lachance - President and COO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Unidentified Analyst - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Anderson Schock - B. Riley Securities Operator Good day and welcome to the InfuSystem Holdings, Inc. Reports First Quarter 2025 Financial Results Conference Call.
InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
InfuSystems Holdings, Inc. (INFU) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.05 per share a year ago.
InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
Neutral
Business Wire
1 month ago
InfuSystem Reports First Quarter 2025 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports First Quarter 2025 Financial Results.
InfuSystem Reports First Quarter 2025 Financial Results
Neutral
Business Wire
1 month ago
InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025.
InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025
Neutral
Business Wire
2 months ago
InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer.
InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer
Neutral
Seeking Alpha
3 months ago
InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q4 2024 Results Conference Call March 4, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - B. Riley Securities Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results Conference Call.
InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
3 months ago
InfuSystems Holdings, Inc. (INFU) Misses Q4 Earnings and Revenue Estimates
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to break-even earnings per share a year ago.
InfuSystems Holdings, Inc. (INFU) Misses Q4 Earnings and Revenue Estimates
Neutral
Business Wire
3 months ago
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024.
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
Neutral
Business Wire
3 months ago
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025.
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Positive
Seeking Alpha
4 months ago
InfuSystem Set For Strong Year
InfuSystem Holdings achieved 11% YoY revenue growth and expanded EBITDA margins by 2.8 percentage points in 3Q24. INFU's business plan focuses on high ROI revenue and less capital-intensive growth through partnerships, leading to higher margins and cash flows. Near-term growth drivers include agreements with Smith+Nephew, SMTI, and Dignitana, expected to boost FY25 revenue and margin expansion.
InfuSystem Set For Strong Year
Charts implemented using Lightweight Charts™